摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-epibatidine dihydrochloride | 152885-09-1

中文名称
——
中文别名
——
英文名称
(+/-)-epibatidine dihydrochloride
英文别名
Epibatidine hydrochloride;(1R,2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane;hydrochloride
(+/-)-epibatidine dihydrochloride化学式
CAS
152885-09-1
化学式
C11H13ClN2*2ClH
mdl
——
分子量
281.613
InChiKey
BLGAWVGDKRRESC-HHDYSPPTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.76
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    24.9
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 安全说明:
    S28,S36/37,S45

反应信息

  • 作为反应物:
    描述:
    L-酒石酸(+/-)-epibatidine dihydrochloride甲醇乙醚 为溶剂, 生成 (+)-epibatidine-l-tartrate
    参考文献:
    名称:
    毒蛙生物碱Ph的绝对构型和药理作用
    摘要:
    在相同种类的毒蛙(Epipedobates anthonyi)中发现了Phantasmidine,它是众所周知的烟碱型乙酰胆碱受体激动剂Epibatidine的刚性同类物。通过手性液相色谱-质谱法与天然对映异构体进行比较,发现天然的潘他ta啶是一种4:1的比例混合物,富含(2a R,4a S,9a S)对映异构体,而合成对映异构体的绝对构型先前是通过Mosher酰胺分析确定的。主要对映异构体在苄基碳上具有与天然表巴替丁相反的S构型,后者的苄基碳为R。合成外消旋体和分离的对映异构体的药理学特征表明,在大多数测试的受体中,比他命啶的效价比表巴替丁低约10倍,但比尼古丁强约100倍。与Epibatidine不同,Pantatasmidine在活性上具有很强的对映选择性,而苄基碳原子具有4a S构型的主要天然对映体则更具活性。与以前对于Epibatidine对映异构体建议的几乎对称构象相比,pha
    DOI:
    10.1021/acs.jnatprod.8b00062
  • 作为产物:
    描述:
    2-氯-5-碘吡啶platinum(IV) oxide 盐酸正丁基锂potassium tert-butylate氢气 、 potassium hydride 作用下, 以 乙酸乙酯甲苯叔丁醇 为溶剂, -70.0~110.0 ℃ 、275.79 kPa 条件下, 反应 32.0h, 生成 (+/-)-epibatidine dihydrochloride
    参考文献:
    名称:
    The synthesis of (+)- and (–)-epibatidine
    摘要:
    描述了生物碱埃比塔丁({exo-2-(2-氯-5-吡啶基)-7-氮杂双环[2.2.1]庚烷})在手性形式下的合成,其中关键步骤是5-锂-2-氯吡啶与N-叔丁氧基羧基-7-氮杂双环[2.2.1]庚-2-酮的反应。
    DOI:
    10.1039/c39930001216
点击查看最新优质反应信息

文献信息

  • The synthesis of (+)- and (–)-epibatidine
    作者:Stephen R. Fletcher、Raymond Baker、Mark S. Chambers、Sarah C. Hobbs、Paul J. Mitchell
    DOI:10.1039/c39930001216
    日期:——
    The synthesis of the alkaloid epibatidine exo-2-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptane} in enantiomeric form involving, as the critical step, reaction or 5-lithio-2-chloropyridine with N-tert-butoxycarbonyl-7-azabicyclo[2.2.1]heptan-2-one is described.
    描述了生物碱埃比塔丁(exo-2-(2-氯-5-吡啶基)-7-氮杂双环[2.2.1]庚烷})在手性形式下的合成,其中关键步骤是5-锂-2-氯吡啶与N-叔丁氧基羧基-7-氮杂双环[2.2.1]庚-2-酮的反应。
  • Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine
    作者:Richard W. Fitch、Barry B. Snider、Quan Zhou、Bruce M. Foxman、Anshul A. Pandya、Jerrel L. Yakel、Thao T. Olson、Nour Al-Muhtasib、Yingxian Xiao、Kevin D. Welch、Kip E. Panter
    DOI:10.1021/acs.jnatprod.8b00062
    日期:2018.4.27
    Phantasmidine, a rigid congener of the well-known nicotinic acetylcholine receptor agonist epibatidine, is found in the same species of poison frog (Epipedobates anthonyi). Natural phantasmidine was found to be a 4:1 scalemic mixture, enriched in the (2aR,4aS,9aS) enantiomer by chiral-phase LC-MS comparison to the synthetic enantiomers whose absolute configurations were previously established by Mosher’s
    在相同种类的毒蛙(Epipedobates anthonyi)中发现了Phantasmidine,它是众所周知的烟碱型乙酰胆碱受体激动剂Epibatidine的刚性同类物。通过手性液相色谱-质谱法与天然对映异构体进行比较,发现天然的潘他ta啶是一种4:1的比例混合物,富含(2a R,4a S,9a S)对映异构体,而合成对映异构体的绝对构型先前是通过Mosher酰胺分析确定的。主要对映异构体在苄基碳上具有与天然表巴替丁相反的S构型,后者的苄基碳为R。合成外消旋体和分离的对映异构体的药理学特征表明,在大多数测试的受体中,比他命啶的效价比表巴替丁低约10倍,但比尼古丁强约100倍。与Epibatidine不同,Pantatasmidine在活性上具有很强的对映选择性,而苄基碳原子具有4a S构型的主要天然对映体则更具活性。与以前对于Epibatidine对映异构体建议的几乎对称构象相比,pha
查看更多

同类化合物

2-(2'-氟-5'-吡啶基)-7-氮杂双环(2.2.1)庚烷 (±)-三色素蛙素 (1S,4R,6S)-6-(6-氯吡啶-3-基)-7-氮杂双环[2.2.1]庚烷 (1R,2R,4S)-2-(6-甲氧基吡啶-3-基)-7-氮杂双环[2.2.1]庚烷 2-fluoro-3-(2'-amino-4'-pyridinyl)deschlorocpibatidine 7-tert-butoxycarbonyl-2-exo-[2'-amino-3'-(pyridin-4-yl)-5'-pyridinyl]-7-azabicyelo[2.2.1]heptane (+/-)-N-Boc-epibatidine 7-carbethoxy-2β-(2-chloro-5-pyridinyl)-3α-carbomethoxy-7-azabicyclo<2.2.1>heptane 7-tert-butoxycarbonyl-2-exo-(2’-fluoro-3‘-(4-benzenesulfonamide)-5‘-pyridinyl)-7-azabicyclo[2.2.1]heptane 7-tert-butoxycarbonyl-2-exo-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptan-3-one 7-tert-butoxycarbonyl-2-endo-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptan-3-one Tert-butyl 2-(6-amino-5-bromopyridin-3-yl)-7-azabicyclo[2.2.1]heptane-7-carboxylate (+/-)-epibatidine dihydrochloride (+)-Epibatidine dihydrochloride 7-carbomethoxy-2-(2-chloro-5-pyridyl)-7-aza-bicyclo[2.2.1]heptane (1R,2R,4S)-2-(6-Methoxy-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane-7-carboxylic acid tert-butyl ester 2-(6-Chloro-5-phenyl-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane (2S)-2-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane Dtxcid1028865 4-((1R,2R,4S)-5-7-Aza-bicyclo[2.2.1]hept-2-yl-2-fluoro-pyridin-3-yl)-benzonitrile [(1R,2R,3S,4S)-7-Benzyl-3-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]hept-2-yl]-((1S,5R,7R)-10,10-dimethyl-3,3-dioxo-3λ6-thia-4-aza-tricyclo[5.2.1.01,5]dec-4-yl)-methanone (-)-epibatidine exo-2-(2'-fluoro-5'-pyridyl)-7-azabicyclo<2.2.1>heptane (1S,2S,4S)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4S)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (+/-)-Epibatidine (1S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-Bromopyridin-3-yl)-7-methyl-7-azabicyclo[2.2.1]heptane 2-(6-Chloro-2-methylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane;hydrochloride 6'-Methylepibatidine 2-(6-(18F)fluoranyl-5-phenylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2R,4R)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane (1S,2S,4R)-2-(6-fluoropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-chloropyridin-3-yl)-7-(111C)methyl-7-azabicyclo[2.2.1]heptane (2R)-2-(6-(18F)fluoranylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (-)-Epibatidine dihydrochloride 5-(7-Azabicyclo[2.2.1]heptan-2-yl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one 3-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptan-2-one 5-[[(2R)-azetidin-2-yl]methoxy]-2-chloropyridine;(1S,2S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(18F)fluoranylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(125I)iodanylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane 2-(6-(123I)iodanylpyridin-3-yl)-7-azabicyclo[2.2.1]heptane (3R,4S)-3-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane epibatidine